|
C20ORF72 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.00319999874321E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.12310000036587E-07 |
| Normal-vs-Stage2 |
1.084450E-02 |
| Normal-vs-Stage3 |
4.41269999984506E-07 |
| Normal-vs-Stage4 |
2.85349999962214E-07 |
| Stage1-vs-Stage2 |
4.528600E-01 |
| Stage1-vs-Stage3 |
2.099600E-01 |
| Stage1-vs-Stage4 |
3.103800E-02 |
| Stage2-vs-Stage3 |
1.277820E-01 |
| Stage2-vs-Stage4 |
3.544100E-02 |
| Stage3-vs-Stage4 |
2.761400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.3224999952437E-08 |
| Normal-vs-AfricanAmerican |
1.518080E-03 |
| Normal-vs-Asian |
1.035160E-04 |
| Caucasian-vs-AfricanAmerican |
7.733200E-01 |
| Caucasian-vs-Asian |
7.934200E-01 |
| AfricanAmerican-vs-Asian |
6.643000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.84659999999637E-05 |
| Normal-vs-Female |
2.17579999572948E-08 |
| Male-vs-Female |
1.900190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64970000005038E-06 |
| Normal-vs-Age(41-60Yrs) |
3.09659999975231E-07 |
| Normal-vs-Age(61-80Yrs) |
7.53620000000232E-05 |
| Normal-vs-Age(81-100Yrs) |
6.899100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.861600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.569600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.717800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.786800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.095600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.050800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.356100E-03 |
| Classical-VS-Follicular |
6.530800E-01 |
| Classical-VS-Other |
8.439000E-01 |
| Classical-VS-Normal |
5.669499999994E-05 |
| Tall-VS-Follicular |
5.403800E-03 |
| Tall-VS-Other |
6.857800E-02 |
| Tall-VS-Normal |
6.71059999790558E-08 |
| Follicular-VS-Other |
9.790400E-01 |
| Follicular-VS-Normal |
1.262600E-03 |
| Other-VS-Normal |
1.534320E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1524000000106E-06 |
| Normal-vs-N1 |
1.64159999999081E-05 |
| N0-vs-N1 |
1.151050E-01 |
|
|
